Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Protagenic Therapeutics ( (PTIX) ) is now available.
Protagenic Therapeutics, Inc. recently closed a private placement deal raising $1.275 million, offering nearly two million shares of common stock and warrants. The funds will bolster the company’s working capital, furthering its mission to innovate in neuro-active peptide therapeutics. As a leader in biopharmaceuticals, Protagenic aims to address stress-related disorders with its cutting-edge treatments.
See more data about PTIX stock on TipRanks’ Stock Analysis page.